{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Houston",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81002",
      "recalling_firm": "Pharm D Solutions, LLC",
      "address_1": "1304 S Loop W",
      "address_2": "N/A",
      "postal_code": "77054-4010",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0145-2019",
      "product_description": "Caffeine and Sodium Benzoate Injection 125 mg/125 mg/mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-1428-02",
      "product_quantity": "567 milliliters",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20180910",
      "center_classification_date": "20181101",
      "termination_date": "20210205",
      "report_date": "20181107",
      "code_info": "Lots: 07192018:88 Discard by: 10/16/2018"
    }
  ]
}